Login

Journal Image
Current Medical Imaging Reviews
ISSN (Print): 1573-4056
ISSN (Online): 1875-6603
VOLUME: 10
ISSUE: 2
DOI: 10.2174/157340561002140715103316      Price:  $58









Dual Time F-18 FDG PET/CT Imaging in the Diagnosis of Renal Cell Cancer

img
Author(s): Savas Karyagar, Zehra Pinar Koc, Sevda S. Karyagar, Tamer Ozulker, Cevat Topal, Ersagun Karaguzel and Tansel Ansal Balci
Pages 134-139 (6)
Abstract:
Background: There are conflicting results in estimation of primary renal tumors by F-18 FDG PET/CT in the literature. Aim of this study is to evaluate diagnostic efficiency of F-18 FDG PET/CT and dual time imaging in the diagnosis of renal cell cancer.

Methods: Dual time F-18 FDG PET/CT examinations of 17 patients (55.2 ± 9.9 years old; 7 F, 10 M) with prediagnosis of renal cell cancer were retrospectively evaluated. All of the patients underwent operation and histopathological results were compared with PET/CT results. In order to compare numerical variables Kolmogorov-Simirnov, Mann Whitney U and Paired samples T tests were performed in SPSS version 15.0 and p<0.05 considered statistically significant.

Results: Among 17 patients 15 patients were confirmed to have renal cell carcinoma, 2 patients had benign pathologies (oncocytoma, metanephritic adenoma). According to the early phase analysis, the sensitivity, specificity, accuracy, positive and negative predictive values of PET/CT regarding diagnosis of primary tumor were 20%, 100%, 29%, 100% and 14%, respectively. Additionally the difference between SUVmax values in the early and the late phase was not statistically significant (p>0.05).

Conclusion: Since only the positive predictive value of PET/CT is sufficiently high and the sensitivity is very low, diagnosis of renal tumors by F-18 FDG PET/CT is not an accurate method. In addition, dual-phase imaging in the diagnosis of renal cell cancer has no benefit.

Keywords:
Dual phase imaging, F-18 FDG, PET/CT, renal cell cancer, renal tumor, SUV.
Affiliation:
Kanuni Training Hospital, Division of Nuclear Medicine, Trabzon, Turkey.